Promising patient data surrounding Retatrutide , specifically the 120 milligram formulation ZPHC ZPHC, reveal a significant benefit on physique decrease and associated health conditions . Researchers posit that this dual acting , affecting both GLP-1 and GIP receptors , may represent a major breakthrough in the treatment of overweight and connecte